Skip to main content

Author: Stone Slade

The Entourage Effect Has a Proof Problem

Cannabis culture has spent years treating the interaction between THC,
minor cannabinoids and terpenes as settled science. A new review suggests the
human evidence is still surprisingly thin.

Spend five minutes in a dispensary and somebody will eventually tell you about the entourage
effect.

Maybe the budtender explains that myrcene makes a cultivar relaxing. Pinene keeps you sharp.
Limonene lifts your mood. CBD smooths out THC. Find the right combination of cannabinoids
and terpenes, and the plant supposedly becomes something greater than the sum of its parts.
By now, it’s practically dispensary gospel.

The problem is that science hasn’t kept pace with our certainty.
A new critical review published in Current Neuropharmacology examined the available evidence
for interactions between THC and other naturally occurring cannabis compounds, focusing
heavily on controlled human studies.

That part matters, because cannabis has a long history of producing exciting results in cells and
animals that become considerably less tidy once actual people get involved.
The researchers’ conclusion was cautious: evidence that minor cannabinoids and terpenes
meaningfully alter THC’s effects in humans remains “exceptionally limited.”
That is not the same thing as saying the entourage effect has been debunked.
Some cannabis compounds clearly interact. Controlled human studies have shown that. What we
don’t have is much evidence supporting the broad, predictable version of the entourage effect
that has become common knowledge in cannabis culture.
And the story gets even stranger when you look at where the idea came from.

The Original Entourage Wasn’t Even About Weed
The phrase “entourage effect” did not originally describe terpenes working alongside THC.
It came from a 1998 paper involving legendary cannabis researcher Raphael Mechoulam and his
colleagues. The researchers were studying 2-AG, one of the body’s own endocannabinoids, when
they found that other naturally occurring fatty compounds present alongside it could increase its
activity.
Those compounds did very little on their own but appeared to enhance the effects of 2-AG.

The researchers called it an “entourage effect.”
No jar of Gelato. No terpene wheel. Nobody explaining why the weed smells like a gas station
inside a fruit stand.

The concept expanded from there.
In 2011, neurologist and cannabis researcher Dr. Ethan Russo published the enormously
influential paper Taming THC: Potential Cannabis Synergy and Phytocannabinoid-Terpenoid
Entourage Effects. Russo collected evidence suggesting cannabinoids and terpenes could interact
in therapeutically useful ways.

That paper helped shape how an entire generation of consumers, growers, brands and cannabis
educators thought about the plant. But Russo’s paper was actually more careful than a lot of the claims that came afterward.

Whendiscussing possible phytocannabinoid-terpene synergy, he included an important qualifier:
“If proven.”
Somewhere between the research paper and the dispensary counter, the “if” mostly disappeared.

Then Humans Got Involved

Pinene is a good example of how quickly a plausible idea can become accepted wisdom.
For years, alpha-pinene has been described as a terpene that might counteract THC-related
memory problems. You can still find that claim on terpene charts and dispensary education
materials all over the place.
Researchers eventually tested it directly.

In a controlled study involving 19 healthy adults, participants inhaled THC alone, alpha-pinene
alone or THC combined with different doses of alpha-pinene.
THC impaired memory and cognitive performance, exactly as expected.
Pinene didn’t save the day.
Even at doses equal to or above what would normally be encountered in cannabis flower, it did
not significantly reduce THC-related memory impairment or meaningfully alter THC’s other
acute effects.

One of the cannabis industry’s favorite terpene talking points finally got a direct human test and
didn’t hold up.
Then researchers tested limonene.

And limonene did something.

Limonene Makes Things More Interesting
Limonene is the citrus-smelling terpene found in cannabis, oranges, lemons and plenty of other
plants.
In a controlled study, 20 adults inhaled different combinations of THC and d-limonene during a
series of double-blind laboratory sessions.
At the highest combination tested, 30 milligrams of THC with 15 milligrams of limonene,
participants reported significantly less anxiety and paranoia than they did after receiving the
same amount of THC alone.

Limonene didn’t simply make them less high. It also didn’t appear to change THC
concentrations in the blood. The effect seemed more selective, reducing some of the anxiety
THC can produce.
That is not nothing.

The study was small, and the highest-dose condition included only a limited number of
participants, so it badly needs replication.
Still, put the pinene and limonene studies next to each other and you start to see why the term
“entourage effect” may be too broad to carry all the weight we’ve placed on it.
Certain molecules may interact with THC in certain ways at certain doses. Some may enhance an
effect. Others may reduce one. Plenty may do absolutely nothing noticeable.
That is a much messier story than the chart behind the dispensary counter.

It is probably also closer to reality.

CBD Blows Up Another Easy Rule
CBD may be the best example of how quickly simple cannabis rules fall apart.
You’ve probably heard that CBD takes the edge off THC.
Sometimes it might.

Under other circumstances, it can apparently do the opposite.
In a randomized Johns Hopkins clinical trial, 18 adults ate brownies containing either 20
milligrams of THC alone or 20 milligrams of THC combined with 640 milligrams of CBD.

The THC-CBD combination produced stronger subjective effects, greater cognitive and
psychomotor impairment and a larger increase in heart rate.
Blood concentrations of THC were also higher.

Researchers believe the enormous oral dose of CBD interfered with enzymes involved in
metabolizing THC, allowing more THC and its active metabolite, 11-hydroxy-THC, to circulate.
That doesn’t mean the little CBD gummy in your nightstand is secretly going to send you to
Mars. The dose used in the study was massive compared with most everyday consumer products,
and oral cannabis has its own unique pharmacology.

But it does wreck the tidy idea that CBD simply “cancels out THC.”
THCV has produced similarly complicated results. In a small controlled human study, THCV
made THC feel weaker to most participants and reduced some of its effects, while at the same
time increasing a particular type of memory error.
So yes, compounds interact.

They just don’t always cooperate.

 

 

Are Terpenes Overrated?
I wouldn’t go that far.

Terpenes are real compounds with real pharmacology. Some have demonstrated biological
effects completely independent of cannabis.
They are also a huge part of what makes good flower good.
Crack open a jar of beautifully grown cannabis and your nose tells you something before a lab
report ever will. Citrus. Gas. Pine. Garlic. Fruit. Flowers. Funk.

Terpenes help define that experience.

What science has not established is that reading a terpene percentage lets us reliably predict
exactly how a particular cultivar will make a human being feel.
That is an important distinction.

We’ve created charts promising that myrcene equals relaxation, limonene equals happiness,
pinene equals focus and linalool equals sleep, almost like cannabis is a Build-A-Bear for
consciousness.

The brain is not that cooperative.

Dose matters. Tolerance matters. Route of administration matters. Metabolism, medications,
previous cannabis exposure and expectations can all play a role. And there is almost certainly
chemistry involved that researchers still don’t fully understand.
Which is exactly why the entourage hypothesis remains worth studying.

And No, This Doesn’t Mean THC Percentage Is King

Before the THC-only crowd takes a victory lap, questioning the entourage effect does not
magically make a 31-percent THC label the final word on cannabis quality.
THC tells us something useful about a product.
It does not tell us whether the flower was grown well, cured properly, stored correctly, tastes
incredible or produces an experience a particular consumer actually enjoys.
And depending on the testing lab, even that THC percentage may not be as precise as the
decimal point makes it look.

Reducing cannabis to one cannabinoid would simply repeat the same mistake from the opposite
direction.

The plant is chemically complicated. Humans are worse.
The eventual answer may be that a handful of cannabinoid-terpene combinations produce
reliable, repeatable effects while dozens of other supposed interactions don’t amount to much.
Fine.

That’s what research is for.

 

Cannabis Deserves Better Than Bro Science
Cannabis spent decades trapped behind prohibition while meaningful research moved at a crawl.
Meanwhile, growers, breeders and consumers kept experimenting with the plant in the real
world.

That created an unusual culture where observations sometimes circulated for decades before
scientists had much opportunity to test them.
Those observations shouldn’t be dismissed.
They also shouldn’t automatically become fact.
The entourage effect is a perfect example.

There are legitimate reasons to believe compounds in cannabis interact. Human research has
already demonstrated some of those interactions. Limonene may alter certain THC effects. Large
doses of CBD can dramatically change the pharmacology of oral THC. THCV appears capable
of modifying parts of the THC experience.

Other popular claims, like pinene preventing THC-induced memory problems, have stumbled
when finally tested in humans.

That isn’t science killing the entourage effect.
It is science finally trying to figure out what the term actually means.
Maybe there is no single grand entourage effect that explains how every cannabinoid and terpene
works together.

Maybe there are dozens, or hundreds, of individual interactions, some important, some
irrelevant, some beneficial, some unpleasant and some dependent entirely on dose, delivery
method or the person consuming them.
I actually find that version a lot more interesting.
For years, we’ve told consumers cannabis is more complicated than a THC number.
Fair enough.

The same humility should apply to the entourage effect.
Parts of it may be real. Parts of it clearly deserve more study. But we don’t get to call the whole
thing settled science just because it sounds right, sells well or fits nicely on a terpene chart.

Tommy Chong: The Last Outlaw of Cannabis Culture

At nearly 88 years old, Tommy Chong is still here.

“I’m still here. I’m having fun. I’m really in a really good space now.”
It is the kind of deceptively simple statement only Tommy Chong could deliver with both humor
and gravity. For most public figures, surviving more than five decades in entertainment would be
achievement enough. But Chong’s life has never followed ordinary celebrity trajectories. His
story is not simply one of fame, nor even solely one of cannabis advocacy. It is the story of a
man who repeatedly found himself at the front edge of cultural revolutions long before the
mainstream was ready to embrace them.

Long before cannabis became a polished corporate industry, before celebrities raced to attach
their names to THC brands, before dispensaries transformed into upscale retail experiences,
Tommy Chong was helping dismantle decades of fear, criminalization, and propaganda
surrounding the plant through one profoundly subversive tool: laughter.
Today, Chong remains one of the most significant living figures in cannabis history, not merely
because he consumed the plant, profited from it, or advocated for it, but because he
fundamentally helped reshape how society perceived it.

His life has touched Motown, Hollywood, counterculture rebellion, federal prison, corporate
cannabis, and political hypocrisy. Through it all, Chong remains exactly what he has always
been: authentic, irreverent, and remarkably self-aware.

“I was chosen,” he joked repeatedly during his recent conversation with Blazed Weekly.
It sounds absurd until one examines the extraordinary historical footprint he has left behind.

BEFORE CANNABIS WAS COOL, TOMMY CHONG
MADE IT HUMAN
For younger generations raised amid legal dispensaries and normalized cannabis markets, it is
difficult to fully appreciate the social and political hostility that once surrounded marijuana in
America.  Cannabis users were not lifestyle consumers.

They were criminals.
Public perception was shaped by decades of weaponized fear, racialized policy, and political
misinformation. Then came Cheech & Chong, whose comedy transformed the cannabis
consumer from societal threat into relatable antihero.
Their records became underground staples. Their films became cultural landmarks. Their humor
pierced through anti-cannabis hysteria with absurdity so effective that it often accomplished what
political arguments could not.
Up in Smoke was not merely a successful comedy. It was one of the earliest mainstream assaults
on prohibitionist mythology, introducing millions of Americans to cannabis consumers as
creative, flawed, hilarious human beings rather than dangerous caricatures.
Tommy Chong did not simply participate in cannabis culture.
He helped humanize it for the masses.
That contribution alone places him among the most important cultural figures in the history of
normalization.

FROM MOTOWN TO COUNTERCULTURE KING
While Tommy Chong’s public identity is deeply intertwined with cannabis, his influence reaches
far beyond it.


Before becoming one-half of the most iconic comedy duo in stoner history, Chong was already
immersed in music culture, working with Bobby Taylor and the Vancouvers during a pivotal era
in American entertainment.

That proximity placed him closer than many realize to the rise of the Jackson 5, a historical
contribution Chong feels has often been erased or minimized.
Speaking on the latest Michael Jackson biopic, Chong was candid in his frustration.
“They have Suzanne De Passe saying she went to Chicago and discovered the Jackson 5. No, no,
that was not true at all. We not only discovered them, but we brought them to Detroit with us.”

He added with equal bluntness:
“Bobby Taylor didn’t exist in the movie.”
For Chong, these omissions represent more than personal slight. They reflect a larger truth about
how history often sanitizes or simplifies the real architects behind cultural shifts.

Throughout his life, Chong has repeatedly occupied this curious space: deeply influential, often
present at pivotal moments, yet frequently under-credited by mainstream historical narratives.
Whether in music, comedy, or cannabis, Tommy Chong often arrived before the culture caught
up.

THE PRICE OF BEING EARLY: PRISON, PIPE
DREAMS, AND THE WOLF OF WALL STREET
Being early, however, often comes at a cost.
When federal authorities targeted Chong during Operation Pipe Dreams, his prosecution was
widely viewed by supporters not merely as law enforcement, but as symbolic punishment.
The government was not simply pursuing a businessman selling glass pipes.
They were making an example of an icon.

“It was an honor to go to jail for the messed up law,” Chong reflected.
His imprisonment became one of the clearest examples of America’s contradictory relationship
with cannabis culture during the early 2000s.
Yet even in prison, Chong found strange opportunity.
“I wrote my memoirs when I was in prison.”

Rather than succumbing to bitterness, Chong embraced writing and reflection. In one of the more
surreal intersections of pop culture history, his incarceration also brought him into close contact
with Jordan Belfort, the infamous Wolf of Wall Street.
As Chong recounts it, Belfort would return from tennis, see Tommy writing, and ask what he was
doing.
“What are you doing?”
“I’m writing.”
“You’re writing a book? I’m gonna write a book.”
Initially, Belfort presented Chong with plagiarized pages. Tommy immediately recognized the
theft, called him out, and then offered the advice that would ultimately help shape Belfort’s
future memoir:
“Write all the stories you’ve been telling me every night.”

Belfort listened.
The resulting work became The Wolf of Wall Street.
After Chong’s release, Belfort reportedly drove by his home honking and shouting:
“Hey! My book’s gonna be a movie! Martin Scorsese is gonna be the director!”
Only Tommy Chong could serve as both cannabis martyr and unlikely literary mentor to one of
Wall Street’s most notorious criminals.

THE SECRET SAUCE: WHY CHEECH & CHONG WORKED
Cheech & Chong’s enduring legacy cannot be explained solely through cannabis.
Their brilliance was artistic.
Their chemistry was rooted in improvisation, rhythm, and authenticity.
“We never rehearsed anything,” Chong explained.
That spontaneity became their defining strength. Their now-legendary “Dave’s Not Here” routine
emerged almost accidentally, born from Tommy stalling while setting up recording equipment.
What could have been an ordinary delay became one of the most recognizable sketches in
comedy history.

Cheech’s character work brought unforgettable voice and cultural texture. Tommy’s musical
background provided pacing, rhythm, and structure.
Together, they created an entirely new comedic framework that felt effortless precisely because it
was genuine.

“We’d get an idea, smoke a joint, go eat… then come back.”
That loose creative formula produced platinum albums, genre-defining films, and an enduring
place in global counterculture.
They were not selling rebellion.
They were documenting it in real time.

CANNABIS LEGALIZATION DIDN’T END THE WAR…
IT JUST CHANGED THE PLAYERS
As cannabis evolved from outlaw economy to legitimate industry, Tommy Chong’s role evolved
with it.

His expanding business ventures, spanning cannabis products, wellness innovation, and THC
consumer markets, positioned him once again near the forefront of industry growth.
Until regulatory systems intervened.

“It was doing great until Gavin Newsom shut us down.”
Chong described how hemp-derived THC opportunities created enormous business potential
before political pressure and entrenched economic interests once again constricted expansion.
“We were set to sign a big deal… that would have put us in the billion-dollar range.”
For Chong, this was not unfamiliar.

The laws had changed. The business structures had evolved. The players had become wealthier.
But the suppression of cannabis whenever it significantly disrupted established industries
remained strikingly familiar.

Legalization, Chong’s career suggests, did not end the struggle surrounding cannabis.
It simply transformed it into something more sophisticated.

AGING OUTLAW, UNDIMINISHED LEGEND
“My whole body forgets that I’m getting old.”
Few people could summarize aging with such perfect Tommy Chong absurdity.
Yet beneath the humor lies something more substantial.
At nearly 88, Chong remains one of the few surviving public figures whose life directly spans
nearly every major chapter of cannabis history: criminalization, activism, cultural rebellion,
legalization, commercialization, and ongoing political warfare.
He is not merely a celebrity attached to cannabis.
He is one of its last great living historians.

His relevance endures because his life story mirrors the broader trajectory of cannabis itself:
misunderstood, persecuted, commodified, but ultimately impossible to erase.

THE FINAL HIT
Tommy Chong’s legacy cannot be reduced to punchlines, nostalgia, or celebrity branding.
He helped normalize cannabis before normalization became profitable.
He endured punishment before legalization became politically convenient.
He transformed fear into laughter, stigma into humanity, and rebellion into mainstream culture.
Many celebrities now profit from cannabis.

Tommy Chong helped make that world possible.
And nearly nine decades in, he remains what he has always been:
Still here. Still standing. Still one of the last true outlaws of cannabis culture.

 

Blazed Media Group
Blazed Magazine | Blazed Weekly News
blazed@blazednews.com| http://BlazedNews.com
1104 S. Mays, Suite Round Rock, TX 78664
403 N Richardson Ave, Roswell, NM 88201
512-897-7823 c.| 575-578-4928 o.

American Weed: The Fight for Legalization and Cannabis Choice

You’d think legalizing a plant would mean the fight is over. But for hemp, the real battle is just
beginning. You’ve probably heard the buzz about cannabis legalization. The headlines paint a rosy picture:
billion-dollar markets, job creation, legal status spreading state by state. On the surface, things
look promising. But behind the headlines, another story is unfolding. If you work in or rely on the hemp industry,
you know exactly what I’m talking about.
Right now, the federally legal hemp market is under systematic attack. This isn’t random or
coincidental. It’s strategic. State by state, bill by bill, hemp products are being regulated out of
existence, even though the federal government explicitly allowed their growth under the 2018
Farm Bill. Texas, predictably, is once again at the epicenter of this battle.

A Legal Industry, Slowly Bled Out
The 2018 Farm Bill legalized hemp federally, provided it contained less than 0.3% Delta-9 THC.
Anything above that threshold remains federally illegal cannabis.
Here’s the kicker: hemp and cannabis are scientifically the same plant, Cannabis sativa L.,
separated only by that thin chemical distinction. This seemingly minor difference set two
industries on a collision course. It opened doors for hemp-derived cannabinoids like CBD,
Delta-9, Delta-8, Delta-10, and HHC. These products, extracted legally from hemp, bypassed the
restrictive regulations surrounding cannabis, spawning a booming alternative market.
Suddenly, consumers across non-legalized states had access to THC products without
dispensaries, inflated costs, or burdensome registrations. Wellness stores across Texas flourished,
offering Delta-8 gummies and other cannabinoid products. Farmers swapped cotton fields for
hemp, small businesses thrived, and consumers enjoyed unprecedented accessibility.
Unsurprisingly, this rapid growth did not sit well with everyone, especially the large multi-state
cannabis operators, alcohol distributors, and special interest groups accustomed to dominating
the market.

When the Lobbyists Show Up
Quickly recognizing hemp’s competitive threat, established cannabis interests mobilized
lobbyists to protect their market share. Their message was simple yet misleading: hemp is
unregulated, unsafe, and poses a public health threat.

In reality, this was never about public health. It was purely about profit margins. New bills
emerged, targeting Delta-8, Delta-10, and other cannabinoids. Suddenly, testing standards
skyrocketed, permits became costly, and regulations grew more restrictive. Step by step, states
dismantled the hemp market they once proudly supported.

Texas: The Tip of the Spear
Nowhere is this shift clearer than Texas, where SB 3 was passed by both chambers in late May
2025 and sent to Governor Greg Abbott’s desk. The bill would have banned virtually every
hemp-derived cannabinoid currently on the market.

But in a surprising move, Abbott vetoed SB 3.
His decision followed massive public pressure: over 100,000 petition signatures, 5,000 letters,
and impassioned testimonies from veterans, farmers, and medical users. Advocates, like crash
survivor Elizabeth Meigs, emphasized how hemp-derived products changed their lives for the
better, underscoring the potential job losses and access issues a ban would cause.
Lt. Gov. Dan Patrick had aggressively pushed for Abbott to sign the bill, framing hemp-derived
THC as a dire public health threat. He continues to ignore data and the experiences of countless
Texans who rely on these products. Abbott, for his part, cited the bill’s overreach and impact on
legal businesses as part of his reasoning.

What’s truly driving this urgency? Powerful lobbyists and industry groups want to shoehorn
hemp products into the outdated alcohol distribution model. That means higher costs, reduced
availability, and a system favoring only the largest operators. One such group, the Coalition for
Adult Beverage Alternatives (C.A.B.A.), which includes beverage giants like Tilray, Keef
Brands, and Wynk, isn’t pushing for an outright hemp ban. Instead, they want regulations that
eliminate small, local competitors.

Beyond Texas: Nationwide Restrictions
Texas isn’t alone. Nationwide, states are rapidly targeting hemp-derived cannabinoids:
• Utah, Nevada, and New Hampshire have enacted strict 0.3% total THC limits, applying
this restriction to all cannabinoids, not just Delta-9 THC.
• Colorado, Iowa, and Minnesota have imposed per-serving THC potency limits,
effectively neutering hemp products’ appeal.
• South Dakota, North Dakota, and Wyoming have banned all isomerized cannabinoids,
allowing only naturally derived Delta-9 THC under the 0.3% threshold.
• Tennessee has introduced costly permits and excessive testing fees that favor large
corporate interests.
• Kentucky finds Delta-8 wrapped up in lawsuits and political gridlock, while Alabama and
Mississippi have banned hemp-derived THC entirely.

Overall, 32 states now impose some form of restrictive regulation on intoxicating hemp products.
This wave of legislative actions isn’t accidental. It’s coordinated, systematically dismantling
small businesses and the innovative markets they created.
The federal government’s failure to anticipate the explosive growth of novel cannabinoids
created this vacuum. It’s now being filled by lobbyists and influential interest groups.


Meanwhile, In Washington
As states act decisively, federal cannabis policy stagnates. Cannabis remains a Schedule I
substance federally, blocking banking access, sensible taxation, and standard regulations.
Agencies capable of intervention remain silent, leaving the industry vulnerable to lobbyists and
political influence.
Worse yet, the latest House Appropriations Committee draft proposes extending the 0.3% THC
cap to all cannabinoids. This would effectively seal the legal loophole that allowed hemp
products to flourish. It would devastate the federally legal hemp businesses that trusted and

operated within existing frameworks, essentially punishing compliance with shifting rules mid-
game.

What’s Really at Stake
Allowing these bans to continue will inevitably consolidate power in the hands of those who
historically fought against cannabis legalization. The hemp market, once vibrant with innovation,
local economic growth, and accessible wellness products, risks being wiped out entirely.
Every new state-level restriction represents a victory, not for safety or regulation, but for
entrenched corporate interests. And if these interests succeed, the core foundation of the modern
cannabis movement, innovation, accessibility and local economies will all vanish.
This isn’t merely about hemp products. It’s about who controls the cannabis industry. It’s about
ensuring adult consumers can make informed choices without interference from powerful
lobbyists or artificially restrictive regulations.
If Americans can responsibly handle opioids, alcohol, and firearms, surely they can manage a
plant.


What’s Next?
The immediate fire may be out in Texas for now, but the threat remains.
Governor Abbott’s veto of SB 3 was a critical win, but it’s not the end. Lawmakers are already
gearing up for a special session to try and work out a new version of the bill. You can bet the
same lobbyists and interest groups will be back at the table, pushing to reintroduce restrictions
under the guise of compromise. If anything, the battle is about to shift into overtime.
Going forward, advocacy must emphasize sensible regulation. Age verification, clear labeling,
potency standards, not outright bans. A unified voice must demand federal clarity through the
next Farm Bill, protecting the hemp industry and its consumers from future legislative overreach.

It’s time to defend the promise of the Farm Bill, support local economies, protect consumer
choice, and recognize that cannabis, whether hemp-derived or otherwise, remains fundamentally
a personal choice. If we fail to act now, we risk losing the cannabis revolution not to regulation, but to a handful of
powerful interests intent on monopolizing this growing market.

Skip to content